Cargando…
Stop the pain: study protocol for a randomized-controlled trial
BACKGROUND: Functional abdominal pain (FAP) is not only a highly prevalent disease but also poses a considerable burden on children and their families. Untreated, FAP is highly persistent until adulthood, also leading to an increased risk of psychiatric disorders. Intervention studies underscore the...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171565/ https://www.ncbi.nlm.nih.gov/pubmed/25212457 http://dx.doi.org/10.1186/1745-6215-15-357 |
_version_ | 1782335911511457792 |
---|---|
author | Warschburger, Petra Calvano, Claudia Becker, Sebastian Friedt, Michael Hudert, Christian Posovszky, Carsten Schier, Maike Wegscheider, Karl |
author_facet | Warschburger, Petra Calvano, Claudia Becker, Sebastian Friedt, Michael Hudert, Christian Posovszky, Carsten Schier, Maike Wegscheider, Karl |
author_sort | Warschburger, Petra |
collection | PubMed |
description | BACKGROUND: Functional abdominal pain (FAP) is not only a highly prevalent disease but also poses a considerable burden on children and their families. Untreated, FAP is highly persistent until adulthood, also leading to an increased risk of psychiatric disorders. Intervention studies underscore the efficacy of cognitive behavioral treatment approaches but are limited in terms of sample size, long-term follow-up data, controls and inclusion of psychosocial outcome data. METHODS/DESIGN: In a multicenter randomized controlled trial, 112 children aged 7 to 12 years who fulfill the Rome III criteria for FAP will be allocated to an established cognitive behavioral training program for children with FAP (n = 56) or to an active control group (focusing on age-appropriate information delivery; n = 56). Randomization occurs centrally, blockwise and is stratified by center. This study is performed in five pediatric gastroenterology outpatient departments. Observer-blind assessments of outcome variables take place four times: pre-, post-, 3- and 12-months post-treatment. Primary outcome is the course of pain intensity and frequency. Secondary endpoints are health-related quality of life, pain-related coping and cognitions, as well as selfefficacy. DISCUSSION: This confirmatory randomized controlled clinical trial evaluates the efficacy of a cognitive behavioral intervention for children with FAP. By applying an active control group, time and attention processes can be controlled, and long-term follow-up data over the course of one year can be explored. TRIAL REGISTRATION: DRKS00005038 (date: 25 July 2013); NCT02030392 (date: 7 January 2014) ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1745-6215-15-357) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4171565 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-41715652014-09-24 Stop the pain: study protocol for a randomized-controlled trial Warschburger, Petra Calvano, Claudia Becker, Sebastian Friedt, Michael Hudert, Christian Posovszky, Carsten Schier, Maike Wegscheider, Karl Trials Study Protocol BACKGROUND: Functional abdominal pain (FAP) is not only a highly prevalent disease but also poses a considerable burden on children and their families. Untreated, FAP is highly persistent until adulthood, also leading to an increased risk of psychiatric disorders. Intervention studies underscore the efficacy of cognitive behavioral treatment approaches but are limited in terms of sample size, long-term follow-up data, controls and inclusion of psychosocial outcome data. METHODS/DESIGN: In a multicenter randomized controlled trial, 112 children aged 7 to 12 years who fulfill the Rome III criteria for FAP will be allocated to an established cognitive behavioral training program for children with FAP (n = 56) or to an active control group (focusing on age-appropriate information delivery; n = 56). Randomization occurs centrally, blockwise and is stratified by center. This study is performed in five pediatric gastroenterology outpatient departments. Observer-blind assessments of outcome variables take place four times: pre-, post-, 3- and 12-months post-treatment. Primary outcome is the course of pain intensity and frequency. Secondary endpoints are health-related quality of life, pain-related coping and cognitions, as well as selfefficacy. DISCUSSION: This confirmatory randomized controlled clinical trial evaluates the efficacy of a cognitive behavioral intervention for children with FAP. By applying an active control group, time and attention processes can be controlled, and long-term follow-up data over the course of one year can be explored. TRIAL REGISTRATION: DRKS00005038 (date: 25 July 2013); NCT02030392 (date: 7 January 2014) ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1745-6215-15-357) contains supplementary material, which is available to authorized users. BioMed Central 2014-09-11 /pmc/articles/PMC4171565/ /pubmed/25212457 http://dx.doi.org/10.1186/1745-6215-15-357 Text en © Warschburger et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Study Protocol Warschburger, Petra Calvano, Claudia Becker, Sebastian Friedt, Michael Hudert, Christian Posovszky, Carsten Schier, Maike Wegscheider, Karl Stop the pain: study protocol for a randomized-controlled trial |
title | Stop the pain: study protocol for a randomized-controlled trial |
title_full | Stop the pain: study protocol for a randomized-controlled trial |
title_fullStr | Stop the pain: study protocol for a randomized-controlled trial |
title_full_unstemmed | Stop the pain: study protocol for a randomized-controlled trial |
title_short | Stop the pain: study protocol for a randomized-controlled trial |
title_sort | stop the pain: study protocol for a randomized-controlled trial |
topic | Study Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171565/ https://www.ncbi.nlm.nih.gov/pubmed/25212457 http://dx.doi.org/10.1186/1745-6215-15-357 |
work_keys_str_mv | AT warschburgerpetra stopthepainstudyprotocolforarandomizedcontrolledtrial AT calvanoclaudia stopthepainstudyprotocolforarandomizedcontrolledtrial AT beckersebastian stopthepainstudyprotocolforarandomizedcontrolledtrial AT friedtmichael stopthepainstudyprotocolforarandomizedcontrolledtrial AT hudertchristian stopthepainstudyprotocolforarandomizedcontrolledtrial AT posovszkycarsten stopthepainstudyprotocolforarandomizedcontrolledtrial AT schiermaike stopthepainstudyprotocolforarandomizedcontrolledtrial AT wegscheiderkarl stopthepainstudyprotocolforarandomizedcontrolledtrial |